Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01469052 · ClinicalTrials.gov registry record · Phase 1
First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT01469052 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 36 participants.
The verdict
NCT01469052, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of the study was to characterize the safety of investigational agent AG-013736, in patients with solid tumors in this First In Human trial.
Interventions
- DRUG AG-013736
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2002-11 |
| Est. Completion | 2004-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01469052
The ClinicalTrials.gov registry entry for NCT01469052 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AG-013736 is the first listed.
NCT01469052 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01469052 about?
NCT01469052 is a clinical study titled "First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors". The purpose of the study was to characterize the safety of investigational agent AG-013736, in patients with solid tumors in this First In Human trial.
What is the current status of trial NCT01469052?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2002-11. Estimated completion is 2004-08.
What interventions are being tested in trial NCT01469052?
The interventions under investigation include: AG-013736 (DRUG).
Who is sponsoring clinical trial NCT01469052?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.